DX3-213B

N/A

Report date: 2022/04/26 16:11:34
NME

Base Information

Drug NameDX3-213B
Drug Alias NameDX3-213BDX-3-213-B
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionATP synthase inhibitors
TargetsATP synthase
Therapy Area/IndicationsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNational Institutes Of Health
China Registration ClassN/A

Develop Information

Active CompaniesNational Institutes Of Health
Inactive CompaniesN/A
Active IndicationsPancreatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A